Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients.

Abstract:

:To assess the impact of chronic viral liver disease (CVLD) on hospital admissions and death in HIV-infected patients since the introduction of highly active antiretroviral therapy, all hospital charts, from January 1996 to December 2000, in a large HIV/AIDS reference center in Madrid were reviewed. Discharge diagnosis, complications during the inpatient period, and number and causes of death were recorded. A total of 1334 hospital admissions involving 875 HIV-infected individuals was recorded. Up to 82% of them were either active or former intravenous drug users. Overall, 158 (11.8%) were admitted because of complications of CVLD, or developed complications of CVLD during their admission for another reason. The absolute number and proportion of admissions caused by CVLD increased over time, from 9.4% (31 of 330) in 1996 to 16% (46 of 287) in 2000 (p < 0.05). Likewise, the total number and proportion of deaths due to CVLD increased from 9.3% (5 of 54) in 1996 to 45% (9 of 20) in 2000 (p < 0.05). Chronic hepatitis C was the only etiology in nearly three-quarters of patients who were admitted or died of CVLD. In conclusion, the proportion of hospital admissions caused by liver failure in HIV-infected patients has increased in the last 5 years, accounting for 16% of cases in 2000. End-stage liver disease currently represents 45% of causes of in-hospital death among HIV-infected individuals. Therefore, strategies to prevent infection by hepatitis viruses (hepatitis B vaccine) and specific treatment (interferon plus ribavirin for hepatitis C virus) should be encouraged among HIV-infected persons.

authors

Martín-Carbonero L,Soriano V,Valencia E,García-Samaniego J,López M,González-Lahoz J

doi

10.1089/08892220152644160

subject

Has Abstract

pub_date

2001-11-01 00:00:00

pages

1467-71

issue

16

eissn

0889-2229

issn

1931-8405

journal_volume

17

pub_type

杂志文章
  • Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal.

    abstract::The use of ritonavir as a protease inhibitor boost is rare in sub-Saharan Africa because a heat-stable formula is not available. We report the results of an open-label pilot trial with unboosted atazanavir in combination with lamivudine and didanosine as first-line therapy conducted in Senegal. Treatment-naive HIV-1 i...

    journal_title:AIDS research and human retroviruses

    pub_type: 临床试验,杂志文章

    doi:10.1089/aid.2009.0123

    authors: Landman R,Diallo MB,Gueye NF,Kane CT,Mboup S,Fall MB,Ndiaye B,Peytavin G,Bennai Y,Benalycherif A,Girard PM,Sow PS

    更新日期:2010-05-01 00:00:00

  • Molecular epidemiology of HIV type 1 subtypes in Taiwan: outbreak of HIV type 1 CRF07_BC infection in intravenous drug users.

    abstract::In Taiwan, sexual transmission is responsible for most HIV-1 infections with two dominant subtypes, subtype B and CRF01_AE, distributing among homosexual and heterosexual groups, respectively. Recently, intravenous drug use has become an emerging route of HIV-1 transmission and contributed to a significant increase of...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2006.22.1055

    authors: Chang SY,Sheng WH,Lee CN,Sun HY,Kao CL,Chang SF,Liu WC,Yang JY,Wong WW,Hung CC,Chang SC

    更新日期:2006-11-01 00:00:00

  • Serological and molecular typing of HIV type 1 infection in the Tiriyo tribe, a native Indian community of the Amazon region of Brazil.

    abstract::The seroprevalence and the occurrence of an HIV-1 subtype was assessed in blood samples of the Tiriyo tribe. Antibody was found in 0.6% and the molecular analysis of the pro region detected the emergence of a subtype B for the first time in a native Indian tribe of the Amazon region of Brazil. ...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2006.22.1267

    authors: Machado LF,Vallinoto AC,Souza MI,Azevedo VN,Ishak MO,Ishak R

    更新日期:2006-12-01 00:00:00

  • High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India.

    abstract::We report one or more HIV resistance mutations in 81.81% of the 33 antiretroviral treatment-experienced study participants with evidence of virologic failure, with M184V being the most commonly observed resistance mutation (69.7%). Two out of four participants with protease inhibitors (PI) experience harbored multiple...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2007.0090

    authors: Sen S,Tripathy SP,Patil AA,Chimanpure VM,Paranjape RS

    更新日期:2007-10-01 00:00:00

  • Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates.

    abstract::A highly purified saponin from Q. saponaria (QS-21) was tested in juvenile rhesus macaques for adjuvant activity and toxicity. The QS-21 was tested alone or as part of an experimental subunit HIV-1 vaccine containing a truncated recombinant HIV-1 envelope protein (gp160D) adsorbed to alum. Antibody responses were meas...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1992.8.1413

    authors: Newman MJ,Wu JY,Coughlin RT,Murphy CI,Seals JR,Wyand MS,Kensil CR

    更新日期:1992-08-01 00:00:00

  • Short communication: the number of HIV major NRTI mutations correlates directly with other antiretroviral-associated mutations and indirectly with replicative capacity and reduced drug susceptibility.

    abstract::While it is known that selection for specific HIV-1 drug resistance-associated mutations (DRM) occurs following ART failure, the patterns of resistance mutations, reduced susceptibility (RS), and replicative capacity (RC) that appear as the number of major NRTI mutations increases have been less well-studied. These ch...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2007.0188

    authors: Ross L,Parkin N,Lanier R

    更新日期:2008-04-01 00:00:00

  • Detection of simian T cell leukemia virus type I infection in seronegative macaques.

    abstract::Simian species of Asian and African origin are naturally infected with the simian T cell leukemia virus type I (STLV-I). Like the closely related human T cell leukemia virus type I (HTLV-I), STLV-I is primarily cell associated, and typical infections exhibit low viral burdens. Four macaques experimentally inoculated w...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1997.13.1147

    authors: Liska V,Fultz PN,Su L,Ruprecht RM

    更新日期:1997-09-01 00:00:00

  • Genetic Analyses of HIV-1 Strains Transmitted from Mother to Child in Northern Vietnam.

    abstract::We previously reported mother-to-child transmission of HIV-1 in nine (6.7%) of 135 children on nevirapine prophylaxis in Vietnam. In the current study, we investigated the appearance and profile of antiretroviral drug (ARV) resistance mutations, the predicted coreceptor usage, and the genetic diversity of HIV-1 strain...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2014.0335

    authors: Phan CT,Pham HV,Bi X,Ishizaki A,Saina M,Phung CD,Khu DT,Ichimura H

    更新日期:2015-08-01 00:00:00

  • Nef and Gag synthetic peptide priming of antibody responses to HIV type 1 antigens in mice and primates.

    abstract::T epitope mapping in human immunodeficiency virus proteins provides a useful tool for AIDS vaccine design. We have previously shown that four peptides selected from the Gag polyprotein of HIV-1 were able to prime mice for in vitro lymphoproliferative responses. These responses were shown to be MHC restricted, and a po...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1994.10.1241

    authors: Vaslin B,Claverie JM,Benveniste O,Barre-Sinoussi FC,Dormont D

    更新日期:1994-10-01 00:00:00

  • HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts.

    abstract::HIV-infected patients are at increased risk of decreased bone mineral density. Some studies have implicated antiretroviral therapy as a contributor to the decreased bone mineral density seen in treated HIV-1 patients. In this study we explore the interactions between protease inhibitors (PI) and primary human osteobla...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2006.0084

    authors: Malizia AP,Cotter E,Chew N,Powderly WG,Doran PP

    更新日期:2007-02-01 00:00:00

  • Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.

    abstract::Herpes simplex virus-2 (HSV-2) suppression with acyclovir or valacyclovir reduces HIV-1 viral RNA levels; one hypothesis is that HSV-2 suppression reduces immune activation. We measured T cell immune activation markers among women participating in a randomized placebo-controlled trial of valacyclovir to reduce HIV-1 R...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/AID.2012.0071

    authors: Roxby AC,Liu AY,Drake AL,Kiarie JN,Richardson B,Lohman-Payne BL,John-Stewart GC,Wald A,De Rosa S,Farquhar C

    更新日期:2013-01-01 00:00:00

  • 9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.

    abstract::Transition from latency to active replication is a crucial stage for the process of human immunodeficiency virus type 1 (HIV-1) infection and life cycle. HIV-1 replication in latently infected cells can be strongly induced by the cytokine tumor necrosis factor alpha (TNF-alpha) and the proliferation-arresting chemical...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1998.14.39

    authors: Moulton S,Pantazis P,Epstein JS,Sadaie MR

    更新日期:1998-01-01 00:00:00

  • Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study.

    abstract::The relationship between adherence to highly active antiretroviral therapy (HAART) and RNA-HIV viral load outcomes has been extensively shown. Although there are different procedures for assessing treatment adherence, there is no ideal method. We present the SERAD (Self-Reported Adherence) questionnaire, a qualitative...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章,多中心研究

    doi:10.1089/aid.2006.0120

    authors: Muñoz-Moreno JA,Fumaz CR,Ferrer MJ,Tuldrà A,Rovira T,Viladrich C,Bayés R,Burger DM,Negredo E,Clotet B,SERAD Validation Team.

    更新日期:2007-10-01 00:00:00

  • Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.

    abstract::Previous studies have demonstrated that lopinavir/ritonavir monotherapy maintained plasma HIV-1 RNA suppression in a large proportion of antiretroviral naive subjects. However, more subjects receiving lopinavir/ritonavir monotherapy experienced confirmed virologic rebound >50 copies/ml compared to a standard three-dru...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/aid.2008.0217

    authors: Campo RE,Da Silva BA,Cotte L,Gathe JC,Gazzard B,Hicks CB,Klein CE,Chiu YL,King MS,Bernstein BM

    更新日期:2009-03-01 00:00:00

  • V3 loop of human immunodeficiency virus type 1 suppresses interleukin 2-induced T cell growth.

    abstract::We tested the effect of three linear or two loop peptides derived from the V3 region of the HTLV-III BH10 clone or the SF2 strain of human immunodeficiency virus type 1 on IL-2-driven T cell proliferation. V3-BH10, which consists of 42 amino acids and has a loop structure, suppressed IL-2-driven proliferation of all I...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1997.13.151

    authors: Sakaida H,Murakami T,Kawamata S,Hattori T,Uchiyama T

    更新日期:1997-01-20 00:00:00

  • Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients.

    abstract::Anemia, a common hematological abnormality in HIV, contributes to decreased quality of life (QOL). This study assessed once-every-2-week epoetin alfa on maintaining QOL and hemoglobin (Hb) in anemic HIV-infected patients in a 24-week, open-label, multicenter study. HIV-infected patients (Hb < or =12 g/dl) received epo...

    journal_title:AIDS research and human retroviruses

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1089/aid.2006.0200

    authors: Levine AM,Salvato P,Leitz GJ,Champs 2 Study Group.

    更新日期:2008-02-01 00:00:00

  • Chimpanzee CXCR4 and CCR5 act as coreceptors for HIV type 1.

    abstract::Chemokine receptors are molecules involved in the fusion of immunodeficiency viruses after their attachment. As chimpanzees are the animal model for infection by HIV-1, we cloned and sequenced chimpanzee CXCR4 and CCR5 from PBMCs. Chimpanzee CXCR4 was found to be identical to human CXCR4, which provides an explanation...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1997.13.1583

    authors: Prétet JL,Zerbib AC,Girard M,Guillet JG,Butor C

    更新日期:1997-12-10 00:00:00

  • Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products.

    abstract::DNA vaccines have the potential of giving rise to a potent cell-mediated immune response by inducing intracellular synthesis and subsequent antigenic presentation of encoded antigens. We have tested a DNA vaccine specific for human immunodeficiency virus type 1 (HIV-1) by the injection of animals with expression plasm...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1995.11.933

    authors: Okuda K,Bukawa H,Hamajima K,Kawamoto S,Sekigawa K,Yamada Y,Tanaka S,Ishi N,Aoki I,Nakamura M

    更新日期:1995-08-01 00:00:00

  • Naturally occurring IgG anti-HLA alloantibody does not correlate with HIV type 1 resistance in Nairobi prostitutes.

    abstract::In an effort to identify an immunological basis for natural resistance to HIV-1 infection, we have examined serum antibody responses to HLA class I antigens in female prostitutes of the Nairobi Sex Workers Study. Anti-HLA antibodies are known to block HIV infectivity in vitro and can be protective against SIV challeng...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1998.14.109

    authors: Luscher MA,Choy G,Njagi E,Bwayo JJ,Anzala AO,Ndinya-Achola JO,Ball TB,Wade JA,Plummer FA,Barber BH,MacDonald KS

    更新日期:1998-01-20 00:00:00

  • High Prevalence of HIV Low Abundance Drug-Resistant Variants in a Treatment-Naive Population in North Rift Kenya.

    abstract::The advent of antiretroviral treatment (ART) has resulted in a dramatic reduction in AIDS-related morbidity and mortality. However, the emergence and spread of antiretroviral drug resistance (DR) threaten to negatively impact treatment regimens and compromise efforts to control the epidemic. It is recommended that sur...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2015.0039

    authors: Cheriro W,Kiptoo M,Kikuvi G,Mining S,Emonyi W,Songok E

    更新日期:2015-12-01 00:00:00

  • The urge for an AIDS vaccine: perspectives from a developing country.

    abstract::AIDS is inexorably involving all parts of the country and all strata of society, with 10% of the urban and 3% of the rural population infected with HIV. It is increasingly a disease of women and children. The major cofactors for transmission are also sexually transmitted. For most developing countries, in spite of all...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1992.8.1535

    authors: Pape JW,Deschamps MM,Verdier RI,Jean S,Desvarieux M,Taverne G,Gelin C,Hyppolite PR,Denize J,Mellon R

    更新日期:1992-08-01 00:00:00

  • Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress.

    abstract::Am important aspect of human immunodeficiency virus (HIV-1) infection is the regulation of its expression by nuclear factor kappa B (NF-kappa B) by redox-controlled signal transduction pathways. In this study, we demonstrate that selenium supplementation can effectively increase glutathione peroxidase (GPx) activity i...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1994.10.1451

    authors: Sappey C,Legrand-Poels S,Best-Belpomme M,Favier A,Rentier B,Piette J

    更新日期:1994-11-01 00:00:00

  • Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection.

    abstract::To determine the role that cellular immune responses play in the protection conferred by vaccination with attenuated SIVmac32H (pC8), we have attempted to deplete macaques of their CD8+ cells prior to challenge with wild-type SIVmac32H (pJ5). In two of four pC8-infected macaques, N109 and N112, a transient partial dep...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1998.14.1187

    authors: Stebbings R,Stott J,Almond N,Hull R,Lines J,Silvera P,Sangster R,Corcoran T,Rose J,Cobbold S,Gotch F,McMichael A,Walker B

    更新日期:1998-09-01 00:00:00

  • A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.

    abstract::Our goal has been to develop a safe and effective system that would allow us to explore the functions of the human immunodeficiency virus (HIV) envelope. We have generated a human lymphoid cell line (TF228.1.16) that stably expresses functional HIV envelope proteins on its cell surface, and therefore closely mimics th...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1993.9.23

    authors: Jonak ZL,Clark RK,Matour D,Trulli S,Craig R,Henri E,Lee EV,Greig R,Debouck C

    更新日期:1993-01-01 00:00:00

  • Downregulation of HLA class I antigen expression in CD4+ T lymphocytes from HIV type 1-infected individuals.

    abstract::The expression of HLA class I antigens is downregulated in CD4+ T cells following in vitro HIV-1 infection. We determined whether the expression of HLA class I antigens is downmodulated in peripheral blood lymphocytes (PBLs) of HIV-1-positive subjects and whether this defect correlates with disease progression. A coho...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1997.13.1509

    authors: Puppo F,Brenci S,Bosco O,Lanza L,Barocci S,Nocera A,Ghio M,Contini P,Setti M,Scudeletti M,Indiveri F

    更新日期:1997-11-20 00:00:00

  • Naturally occurring sequence polymorphisms within HIV type 1 group O protease.

    abstract::Mutations within the protease gene associated with reduced susceptibility to protease inhibitors have been well documented for HIV-1 group M subtype B strains. In contrast, limited genotypic and phenotypic information is available for the genetically diverse HIV-1 group O strains. Preexisting resistance-associated pol...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/08892220152644269

    authors: Luk KC,Kaptué L,Zekeng L,Soriano V,Gürtler L,Devare SG,Schochetman G,Hackett J Jr

    更新日期:2001-11-01 00:00:00

  • HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

    abstract::HIV-1 Nef has been demonstrated to be integral for viral persistence, infectivity, and the acceleration of disease pathogenesis (AIDS) in humans. Nef has also been detected in the plasma of HIV-infected individuals and is released from infected cells. The form in which Nef is released from infected cells is unknown. H...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2009.0170

    authors: Raymond AD,Campbell-Sims TC,Khan M,Lang M,Huang MB,Bond VC,Powell MD

    更新日期:2011-02-01 00:00:00

  • EBV-induced human B cell lymphomas in hu-PBL-SCID mice.

    abstract::Epstein-Barr virus (EBV) infection is associated with Burkitt's lymphoma (BL) in normal individuals and immunoblastic B cell lymphomas in immunosuppressed or HIV-infected individuals. SCID mice reconstituted with human peripheral blood leukocytes (hu-PBL-SCID) from EBV-seropositive donors also may develop spontaneous ...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章,评审

    doi:

    authors: Mosier DE,Picchio GR,Kirven MB,Garnier JL,Torbett BE,Baird SM,Kobayashi R,Kipps TJ

    更新日期:1992-05-01 00:00:00

  • Lubricant Provides Poor Rectal Mucosal HIV Coverage.

    abstract::Given the rising HIV incidence in men who have sex with men (MSM) despite repeatedly proven effectiveness of oral HIV pre-exposure prophylaxis, behaviorally congruent periodic dosing strategies, such as dosing microbicides as lubricants, are now in demand. Rectal microbicide gel studies largely administer gels using v...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2016.0318

    authors: Shieh EC,Weld ED,Fuchs EJ,Hiruy H,Buckheit KW,Buckheit RW Jr,Breakey J,Hendrix CW

    更新日期:2017-08-01 00:00:00

  • Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display.

    abstract::The humoral immune response is a mechanism that potently suppresses or prevents viral infections. However, genetic diversity and resistance to antibody-mediated neutralization are serious obstacles in controlling HIV-1 infection. In this study, we isolated monoclonal antibodies from an SIV-infected macaque by using th...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2010.0191

    authors: Kuwata T,Katsumata Y,Takaki K,Miura T,Igarashi T

    更新日期:2011-05-01 00:00:00